Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Cardiac Amyloidosis Clinical Trials

12 recruiting trials for Cardiac Amyloidosis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
12
Total Trials
12
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT07154394

Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease

This study seeks to explore the possible common pathogenesis of both cardiac amyloidosis and Alzheimer's disease, which can both be associated with amyloid deposits. Using...

Sponsor: University Hospital, EssenEnrolling: 151 location
RECRUITINGNCT07336394

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance...

What is this study about? This research is focused on improving the care for people with rare heart muscle diseases, known as rare cardiomyopathies. These are uncommon conditions...

Sponsor: Chinese Academy of Medical Sciences, Fuwai HospitalEnrolling: 10001 location
RECRUITINGNCT05101304

Registre HEAR, Healthcare European Amyloidosis Registry

This is a non-interventional, prospective, retrospective, non-comparative, multi-center study. In order not to interfere with patient management, the study is observational....

Sponsor: Saving Lives MattersEnrolling: 50001 location
RECRUITINGNCT06129656

Cardiac Amyloidosis Registry of University Hospital Leipzig

This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about...

Sponsor: University of LeipzigEnrolling: 5001 location
RECRUITINGNCT06610019

Cardiovascular Multimodality Imaging Study

Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk for cardiovascular...

Sponsor: Montefiore Medical CenterEnrolling: 50001 location
RECRUITINGNCT06799273

MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis

This study aims to advance the understanding of cardiac amyloidosis, its effects on exercise capacity, and its prognostic implications. By conducting a systematic investigation...

Sponsor: Centro Cardiologico MonzinoEnrolling: 14001 location
RECRUITINGNCT04849754

Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy

Recently, treatment with tafamidis in patients with cardiac ATTR lead to a significant reduction in mortality. The Perugini score is commonly used on planar bone scans to...

Sponsor: GCS Ramsay Santé pour l'Enseignement et la RechercheEnrolling: 301 location
RECRUITINGNCT06427304

Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older...

Sponsor: Gérond'ifEnrolling: 63720 locations
RECRUITINGNCT06458374

ATTR Cardiac Amyloidosis in a Selected Population

Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be...

Sponsor: Helse Møre og Romsdal HFEnrolling: 1801 location
RECRUITINGNCT07130565

Pan-Amyloid PET/CT in Various Amyloid-Related Disease

To evaluate the potential usefulness of 18F-92/AV45/TPZA/FT8, 11C-PIB positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions...

Sponsor: Tianjin Medical UniversityEnrolling: 5002 locations
RECRUITINGNCT07232459

[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis

\[18F\]FT8, a derivative of 1-(4-pyridyl)-4-piperazinyl arene (\[18F\]TPZA), exhibits high affinity for AL amyloid in myocardial tissue sections and shows no significant binding...

Sponsor: Tianjin Medical UniversityEnrolling: 252 locations
RECRUITINGPhase 1NCT06790394

Test-retest Study With [18F]FBB in Cardiac Amyloidosis

This study is an open-label study to evaluate and characterize test-retest reliability of \[18F\]florbetaben PET in subjects with AL-CA and ATTR-CA compared to non-CA subjects....

Sponsor: Life Molecular Imaging GmbHEnrolling: 152 locations